ArticleJournal of cancer research and clinical oncology2015

Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.

Ci Hui Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.